Medicines Evaluation Unit - About Us

The Medicines Evaluation Unit is a joint venture with a major university hospital and covenants all profits (through its charitable status) to support research in respiratory medicine. The Unit was first established in 1994 and is owned by the North West Lung Centre charity.

The MEU specialises in performing clinical trials (from Phase I through to IV) in respiratory / inflammatory medicine and related areas. With the company’s position within hospital premises it has the advantages of specialist equipment and ITU access availability, and is therefore ideally suited to perform early phase exploratory studies.

The MEU has an outstanding reputation for performing high quality clinical research complying with UK Clinical Trials Legislation and EU Directives 2001/20/EC and 2005/28/EC. The Unit has received a successful GCP inspection by the MHRA (December 2008) MHRA Phase I Standard and Supplementary Accredited site.